Outlook Therapeutics has finalized the analysis of 12-week safety and efficacy data from the NORSE E...

Prevent Blindness, a leading organization dedicated to promoting eye health, announced it has receiv...

Inflammasome Therapeutics has announced encouraging 3-month topline results from a clinical trial ev...

4D Molecular Therapeutics (4DMT) has released promising topline interim data from Part 1 of the SPEC...

Ocugen, Inc. has announced encouraging 2-year safety and efficacy results from its Phase 1/2 clinica...

AbbVie and Regenxbio have announced updates on the clinical development of ABBV-RGX-314, a potential...

PulseSight Therapeutics SAS has submitted a clinical trial authorization (CTA) to the Agence Nationa...

Sling Therapeutics has revealed positive topline efficacy and safety results from the Phase 2b/3 LID...

Samsara Vision has reported promising intermediate-term visual and safety outcomes for the SING IMT ...

Formycon AG, in partnership with Teva Pharmaceuticals International GmbH and Klinge Biopharma GmbH, ...